Outpatient Medicine Update-New Evidence for Common Conditions

Video Transcription

Video Summary

The presentation reviews recent evidence and guidelines across common conditions:

- <strong>Obesity:</strong> ACP favors lifestyle changes plus medication; semaglutide or tirzepatide are preferred options for eligible patients.
- <strong>Menopausal hormone therapy:</strong> A large observational study found no increase in overall mortality; use for three to under ten years was associated with lower mortality, with transdermal therapy appearing favorable.
- <strong>Prostate screening:</strong> A PSA below 1 predicted low long-term cancer incidence, though screening intervals may need to account for individual risk, including race.
- <strong>Hypertension:</strong> Updated guidance emphasizes risk-based treatment, a usual goal below 130/80, accurate measurement, and consideration of primary aldosteronism testing. Low diastolic pressure was not linked to cognitive decline in the reviewed analysis.
- Other studies suggest levothyroxine can be taken with food if dosing is adjusted; home HPV sampling may expand cervical screening; extended anticoagulation may prevent recurrent clots; and continuing caffeine after cardioversion may reduce atrial fibrillation recurrence.

These findings should be interpreted alongside clinical guidelines and individual patient circumstances.

Keywords

obesity treatment

menopausal hormone therapy

prostate screening

hypertension guidelines

levothyroxine with food

home HPV sampling